Adults 18 to 65, female only, with Health. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Eyelash Length as Measured by Digital Image Analysis (DIA)Primary· Baseline
Photographs were taken of the eyelashes. Length was measured in millimeters. Data from both eyes were averaged for each participant for analysis.
Group
Value
95% CI
Healthy Females
7.33
3.99 – 10.10
Eyelash Thickness as Measured by Digital Image Analysis (DIA)Secondary· Baseline
Photographs were taken of the eyelashes. Eyelash thickness/fullness was assessed across both eyes as an average of the 3 preset areas measured in millimeters squared (mm\^2).
Group
Value
95% CI
Healthy Females
1.39
0.32 – 3.13
Eyelash Darkness as Measured by Digital Image Analysis (DIA)Secondary· Baseline
Photographs were taken of the Eyelashes. Eyelash darkness (intensity) was measured within the spline (a narrow area approximately 5 pixels wide that bisects the area of interest). Eyelash darkness was measured in both eyes and averaged for analysis using a scale where 0=black and 255=white.
Group
Value
95% CI
Healthy Females
122.2
64.7 – 162.5
Sponsor's own description
This study will asses epidemiologic changes in eyelash characteristics with increasing age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07261085 — A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Me
· active not recruiting
NCT05659381 — Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
· Phase 3
· recruiting
NCT05567237 — Effects of Microcurrent Treatment With and Without Resistance Exercises
· NA
· recruiting
NCT04808180 — Clinical Efficacy of Biomimetic Hydroxyapatite in the Treatment of Molar Incisor Hypomineralization.
· NA
· completed
Other recruiting trials for Health
Currently open trials in the same condition.
NCT07356492 — Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Servicemembers and Veterans: A Precision Me
· NA
· recruiting
NCT06854536 — A Study on the Changes and Prognosis of Intestinal Microbiota and Function in Infants With Food Allergies
· active not recruiting
NCT06691100 — How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
· NA
· recruiting
NCT06360055 — Effect of Oral D-mannose Tablets on Pharmacokinetics of Dabigatranate in Healthy Adults
· NA
· recruiting
NCT06157346 — Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude
· recruiting
Other Allergan trials
Trials by the same sponsor.
NCT04609020 — Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment
· Phase 4
· completed
NCT05452070 — A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft
· Phase 3
· completed
NCT05393089 — Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopi
· Phase 2
· withdrawn
NCT05152576 — A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants Wi
· Phase 2
· completed
NCT05088980 — Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbita
· Phase 3
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Allergan
Last refreshed: 1 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01518270.